Stock Trading Canary

United States · SEC Form 4 · Snapshot date: 2026-10-18 · Built: 2026-10-18 · 中文

← United States · Coverage record

US · SEC FORM 4

TELA Bio, Inc.

TELA · Nasdaq · CIK 0001561921 · Healthcare · Medical Devices

INSIDER SIGNAL

52.8 / 100

2 buyers · 6 purchase transaction lines · $186.2K gross purchase

WHY THIS SIGNAL?

Buyer breadthLow
Purchase sizeLow
RoleModerate
RecencyModerate
ConvictionStrong
Score anatomy

Each bar shows the contribution to the current score; the weights and formula stay unchanged.

Cluster+14.0 / 35
Purchase size+9.8 / 25
Role+13.0 / 20
Recency+6.0 / 10
Conviction+10.0 / 10

What is holding the score back?

  • ⚠ Cluster breadth is moderate · 2 insider(s), not 4+
  • ⚠ Purchase size is modest relative to the model scale
  • ⚠ Role scores low · most senior buyer: Chief Executive Officer (CEO, chair and 10% owners score lowest)

Purchase-size comments are relative to the model scale. Average daily volume is a separate market-context diagnostic.

US-v1.2 ranks qualifying equity purchases under the current 180-day rules. The score is a research priority, not a return forecast or probability. Backtests have not shown that a higher US score is followed by better returns.

Insider activity timeline

Owner lanes show the latest 180 days. Symbol shape identifies the transaction type; sales remain context only.

AprMayJunJulAugSepOct
Capper Joseph HDirector
○○●●●●
Getz Heather CChief Executive Officer
○●●
Plovanic William J.Director
○○
THOMAS PAULDirector
○
Rocchio Betty JoDirector
○
NOHRA GUY PDirector
○
● Purchase▼ Sale○ Other

Showing the six most active owners; 1 additional owner(s) remain in Form 4 evidence.

Purchase breadth & concentration

QUALIFYING BUYERS2
PURCHASE CONCENTRATION90%Largest buyer: Capper Joseph H · $167.5K
CLUSTER BUYING · 15D1 insiderPeak activity: 2026-08-14–2026-08-17

Roles in the peak window: Chief Executive Officer. Concentration uses priced qualifying P lines only and does not change the saved score.

SIGNAL HISTORY

52.8 / 100

Latest recorded score

↓ -0.2 ptsversus the previous recorded snapshot
  1. 53.4
  2. 53.3
  3. 53.1
  4. 53.0
  5. 52.8

Only scores saved when a full US scoring run completed are shown; gaps are not reconstructed.

Recent Form 4 activity

7Purchases
0Sales
32Other Form 4 lines
21SEC filings · 365 days
BUYING6 qualifying P line(s) · 180 days
SELLING0 sale line(s) · context only
OTHER13 exercise / withholding / award / gift / other lines
10b5-1 / PLANNEDNot assessed

P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.

Market context

Market context provides additional background on recent price performance and risk. It does not affect the Insider Signal.

Price performance

1M
+22.7%
3M
+35.9%
6M
+95.8%
12M
-27.5%

Volatility & liquidity

Volatility
86.7%
Beta
—
Avg daily value
USD 241,453

Valuation

Market cap
USD 49.8M
P/E
—

Fundamentals

Profit margin
-48.3%
ROE
-614.6%
Industry
Medical Devices

Market data

Price data up to: 2026-10-11 · Price source: OpenBB/yfinance; volume from price cache (yfinance) · From SEC filings: Market cap, Profit margin, ROE · Fiscal year ended: 2025-12-31 · Market cap is the shares outstanding stated on the filing cover multiplied by the latest close. Share count date: 2026-08-05 · Status: PASS

Short interest

Short interest is external context reported to FINRA by broker-dealers. It does not affect the Insider Signal.

Shares short
469,145
Previous report
550,824
Avg daily volume
261,819
Days to cover
1.8

FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.

Historical equity purchases

Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.

Transaction dateReporting ownerTypeSecuritySharesAvg. priceApprox. valueSource
2026-09-17Capper Joseph HPurchase (P)Common Stock25,000USD 1.22USD 30,500SEC filing ↗
2026-09-16Capper Joseph HPurchase (P)Common Stock50,000USD 1.17USD 58,500SEC filing ↗
2026-09-15Capper Joseph HPurchase (P)Common Stock50,000USD 1.06USD 53,000SEC filing ↗
2026-09-14Capper Joseph HPurchase (P)Common Stock25,000USD 1.02USD 25,500SEC filing ↗
2026-08-17Getz Heather CPurchase (P)Common Stock12,500USD 0.66USD 8,250SEC filing ↗
2026-08-14Getz Heather CPurchase (P)Common Stock15,000USD 0.70USD 10,500SEC filing ↗
2025-11-17EW HEALTHCARE PARTNERS FUND 2, L.P.; EW HEALTHCARE PARTNERS FUND 2-A, L.P.; EW Healthcare Partners Fund 2 GP, L.P.; EW Healthcare Partners Fund 2-UGP, LLCPurchase (P)Common Stock, par value $0.001 per share3,604,000USD 1.11USD 4,000,440SEC filing ↗
2024-10-24Talmo PaulPurchase (P)Common Stock22,222USD 2.25USD 50,000SEC filing ↗
2024-10-24KOBLISH ANTONYPurchase (P)Common Stock88,888USD 2.25USD 199,998SEC filing ↗
2024-10-24Firestone Gregory A.Purchase (P)Common Stock6,666USD 2.25USD 14,998SEC filing ↗
2024-10-24Cuca RobertoPurchase (P)Common Stock64,444USD 2.25USD 144,999SEC filing ↗
2023-12-05Firestone Gregory A.Purchase (P)Common Stock2,600USD 5.65USD 14,690SEC filing ↗
2023-11-14KOBLISH ANTONYPurchase (P)Common Stock11,000USD 4.54USD 49,940SEC filing ↗
2023-11-14Cuca RobertoPurchase (P)Common Stock10,000USD 4.49USD 44,900SEC filing ↗
2022-11-03Opaleye Management Inc.Purchase (P)Common Stock, par value $0.001 per share20,262USD 7.81USD 158,246SEC filing ↗

Form 4 evidence

39 transaction lines in the latest 365-day window; 397 in local history.

DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-09-17Capper Joseph HPurchase (P)Common Stock25,000USD 1.22USD 30,500SEC filing ↗
2026-09-16Capper Joseph HPurchase (P)Common Stock50,000USD 1.17USD 58,500SEC filing ↗
2026-09-15Capper Joseph HPurchase (P)Common Stock50,000USD 1.06USD 53,000SEC filing ↗
Show recent Form 4 evidence (30 grouped rows)
DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-09-17Capper Joseph HPurchase (P)Common Stock25,000USD 1.22USD 30,500SEC filing ↗
2026-09-16Capper Joseph HPurchase (P)Common Stock50,000USD 1.17USD 58,500SEC filing ↗
2026-09-15Capper Joseph HPurchase (P)Common Stock50,000USD 1.06USD 53,000SEC filing ↗
2026-09-14Capper Joseph HPurchase (P)Common Stock25,000USD 1.02USD 25,500SEC filing ↗
2026-08-17Getz Heather CPurchase (P)Common Stock12,500USD 0.66USD 8,250SEC filing ↗
2026-08-14Getz Heather CPurchase (P)Common Stock15,000USD 0.70USD 10,500SEC filing ↗
2026-08-03Getz Heather CAward / grant (A)Common Stock500,000USD 0.00USD 0SEC filing ↗
2026-07-15Plovanic William J.Award / grant (A)Common Stock20,930USD 0.79USD 16,535SEC filing ↗
2026-07-15Capper Joseph HAward / grant (A)Common Stock6,227USD 0.79USD 4,919SEC filing ↗
2026-06-09THOMAS PAULAward / grant (A)Common Stock23,600USD 0.00USD 0SEC filing ↗
2026-06-09Rocchio Betty JoAward / grant (A)Common Stock11,675USD 0.00USD 0SEC filing ↗
2026-06-09Plovanic William J.Award / grant (A)Common Stock11,675USD 0.00USD 0SEC filing ↗
2026-06-09NOHRA GUY PAward / grant (A)Common Stock23,600USD 0.00USD 0SEC filing ↗
2026-06-09NEELS GUIDO JAward / grant (A)Common Stock23,600USD 0.00USD 0SEC filing ↗
2026-06-09Capper Joseph HAward / grant (A)Common Stock23,600USD 0.00USD 0SEC filing ↗
2026-02-24KOBLISH ANTONYTax withholding (F)Common Stock3,900USD 0.79USD 3,081SEC filing ↗
2026-02-23Talmo PaulTax withholding (F)Common Stock4,061USD 0.77USD 3,127SEC filing ↗
2026-02-23Smeykal MeganTax withholding (F)Common Stock423USD 0.77USD 326SEC filing ↗
2026-02-23KOBLISH ANTONYTax withholding (F)Common Stock11,631USD 0.77USD 8,956SEC filing ↗
2026-02-23Firestone Gregory A.Tax withholding (F)Common Stock1,352USD 0.77USD 1,041SEC filing ↗
2026-02-23Cuca RobertoTax withholding (F)Common Stock5,234USD 0.77USD 4,030SEC filing ↗
2026-02-21Talmo PaulTax withholding (F)Common Stock3,385USD 0.72USD 2,437SEC filing ↗
2026-02-21Smeykal MeganTax withholding (F)Common Stock1,590USD 0.72USD 1,145SEC filing ↗
2026-02-21KOBLISH ANTONYTax withholding (F)Common Stock12,494USD 0.72USD 8,996SEC filing ↗
2026-02-21Firestone Gregory A.Tax withholding (F)Common Stock4,189USD 0.72USD 3,016SEC filing ↗
2026-02-21Cuca RobertoTax withholding (F)Common Stock4,780USD 0.72USD 3,442SEC filing ↗
2026-02-20Talmo PaulAward / grant (A)Common Stock57,000USD 0.00USD 0SEC filing ↗
2026-02-20KOBLISH ANTONYAward / grant (A)Common Stock176,000USD 0.00USD 0SEC filing ↗
2026-02-20Firestone Gregory A.Award / grant (A)Common Stock37,000USD 0.00USD 0SEC filing ↗
2026-02-20Cuca RobertoAward / grant (A)Common Stock57,000USD 0.00USD 0SEC filing ↗

Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.

Snapshot & identity

Snapshot date2026-10-18
Ranking versionUS-v1.2
Data qualityPASS ELIGIBLE · —
TickerTELA
CIK0001561921
SectorHealthcare
IndustryMedical Devices Yahoo Finance
SEC SIC3841 Surgical & Medical Instruments & Apparatus
ExchangeNasdaq

Data coverage

Local Form 4 history397 transaction lines from 2020-04-01 to 2026-09-17
243 P purchase lines · 6 S sale lines · 148 other lines
SEC company submissionsOpen SEC filings ↗

Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.